期刊文献+

糖尿病足患者血清胆红素水平变化 被引量:2

下载PDF
导出
摘要 目的观察糖尿病足患者血清胆红素水平变化。方法选取62例糖尿病足患者(观察1组)、62例2型糖尿病无足部病变患者(观察2组)和98例健康体检者(对照组),采用全自动生化分析仪测定三组血清总胆红素(TBIL)、直接胆红素(DBIL)、间接胆红素(IBIL)。结果观察1组、观察2组、对照组血清TBIL分别为(11.50±4.86)、(13.52±4.90)、(18.07±8.31)μmol/L,血清DBIL分别为(4.33±3.25)、(4.29±1.52)、(4.79±2.26)μmol/L,血清IBIL分别为(7.19±3.36)、(9.24±4.05)、(13.28±6.85)μmol/L,三组间血清TBIL、IBIL比较,P均<0.05。观察1组与观察2组Hb A1c≤8%者TBIL分别为(12.40±2.64)、(13.93±5.74)μmol/L,血糖控制不佳者(Hb A1c>8%)TBIL分别为(10.37±1.01)、(13.28±3.52)μmol/L,观察1组Hb A1c≤8%者TBIL与Hb A1c>8%者比较,P<0.05;观察1组Hb A1c≤8%者TBIL与观察2组比较,P均<0.05。结论糖尿病足患者血清胆红素水平降低,尤其是血糖控制不佳者血清胆红素水平降低更明显。
出处 《山东医药》 CAS 北大核心 2015年第3期84-85,共2页 Shandong Medical Journal
  • 相关文献

参考文献13

  • 1Johannesson A,Larsson GU,Ramstrand N,et al.Incidence of lower-limb amputation in the diabetic and nondiabetic general population:a 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations[J].Diabetes Care,2009,32(2):275-280. 被引量:1
  • 2Tapan S,Dogru T,Tasci I,et al.Soluble CD40ligand and soluble P-selectin levels in Gilbert's syndrome:a link to protection against atherosclerosis[J].Clin biochem,2009,42(9):791-795. 被引量:1
  • 3Inoguchi T,Sasaki S,Kobayashi K,et al.Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes[J].JAMA,2007,298(12):1398-1400. 被引量:1
  • 4Albeti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(7):539-553. 被引量:1
  • 5Apelqvist J,Bakker K,van Houtum WH,et al.International consensus and practical guidelines on the management and the prevention of the diabetic foot.International Working Group on the Diabetic Foot[J].Diabetes Metab Res Rev,2000,16(1):s84-92. 被引量:1
  • 6Chalya PL,Mabula JB,Dass RM,et al.Surgical management of diabetic foot ulcers:a Tanzanian university teaching hospital experience[J].BMC Res Notes,2011,(4):365. 被引量:1
  • 7Tesfaye S,Boulton AJ,Dyck PJ,et al.Diabetic neuropathies:update on definitions,diagnostic criteria,estimation of severity,and treatments[J].Diabetes Care,2010,33(10):2285-2293. 被引量:1
  • 8Ko GT,Chan JC,Woo J,et al.Serum bilirubin and cardiovascular risk factors in a Chinese population[J].J Cardiovasc Risk,1996,3(5):459-463. 被引量:1
  • 9Cheriyath P,Gorrepati VS,Peters I,et al.High total bilirubin as a protective factor for diabetes mellitus:an analysis of NHANES data from 1999-2006[J].J Clin Med Res,2010,2(5):201-206. 被引量:1
  • 10Jung CH,Lee MJ,Kang YM,et al.Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men:A 4 year retrospective longitudinal study[J].Metabolism,2014,63(1):87-93. 被引量:1

同被引文献3

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部